Study to Determine the Bioequivalence of Two Products Containing Rosuvastatin (20 mg/Tablet)
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the bioequivalence of Rosuvastatin/ Verisfield 20
mg film-coated tablets and Crestor™/ AstraZeneca 20 mg film-coated tablets.